New study unlocks genetic secrets of rare blood clots
NCT ID NCT07329725
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how genes, lifestyle factors, and treatments affect survival and recovery in people with visceral venous thrombosis (a rare blood clot in the belly organs). Researchers will follow 101 adults to understand what drives the disease and how best to manage it. The goal is to improve care for future patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 101 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Dec 2025
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients diagnosed with visceral venous thrombosis, including portal, mesenteric, splenic, renal and hepatic vein thrombosis in Department of Internal Medicine, Sohag University Hospital.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adult patients (≥ 18 years) with radiologically confirmed visceral venous thrombosis. * Availability of complete clinical, laboratory, and imaging data at diagnosis. * Patients who consent to participate and provide blood samples for genetic testing. Exclusion Criteria: * Isolated lower-limb deep-vein thrombosis or pulmonary embolism without visceral involvement. * Patients with incomplete records precluding outcome assessment. * Refusal or inability to provide informed consent * Patients lost to follow-up within the first three months of diagnosis.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Visceral venous thrombosis are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sohag University
Sohag, 82511, Egypt